Edition:
United States

Boston Scientific Corp (BSX)

BSX on New York Consolidated

23.57USD
29 Sep 2016
Change (% chg)

$-0.18 (-0.76%)
Prev Close
$23.75
Open
$23.74
Day's High
$23.82
Day's Low
$23.55
Volume
1,139,353
Avg. Vol
9,430,707
52-wk High
$24.79
52-wk Low
$15.67

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 0.27 December 29 Sep 2016

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 11 10 10 10
(2) OUTPERFORM 10 11 11 12
(3) HOLD 5 6 6 6
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.77 1.85 1.85 1.86

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-16 21 2,070.95 2,102.00 2,055.00 2,019.21
Quarter Ending Dec-16 21 2,154.45 2,182.00 2,128.00 2,106.74
Year Ending Dec-16 23 8,311.19 8,370.00 8,215.00 8,089.75
Year Ending Dec-17 25 8,768.47 8,929.00 8,478.00 8,486.75
Earnings (per share)
Quarter Ending Sep-16 25 0.27 0.28 0.26 0.27
Quarter Ending Dec-16 25 0.29 0.30 0.28 0.29
Year Ending Dec-16 26 1.10 1.12 1.08 1.06
Year Ending Dec-17 27 1.26 1.33 1.18 1.20
LT Growth Rate (%) 7 12.75 18.30 8.60 11.68

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-16 2,045.70 2,126.00 80.30 3.93
Quarter Ending Mar-16 1,912.80 1,964.00 51.20 2.68
Quarter Ending Dec-15 1,994.16 1,978.00 16.16 0.81
Quarter Ending Sep-15 1,861.51 1,888.00 26.49 1.42
Quarter Ending Jun-15 1,833.67 1,843.00 9.33 0.51
Earnings (per share)
Quarter Ending Jun-16 0.27 0.27 0.00 1.66
Quarter Ending Mar-16 0.24 0.28 0.04 15.99
Quarter Ending Dec-15 0.25 0.26 0.01 5.56
Quarter Ending Sep-15 0.23 0.24 0.01 6.15
Quarter Ending Jun-15 0.21 0.22 0.01 2.76

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-16 2,070.95 2,070.65 2,071.89 2,043.01 2,019.21
Quarter Ending Dec-16 2,154.45 2,154.32 2,154.07 2,115.81 2,106.74
Year Ending Dec-16 8,311.19 8,310.56 8,311.70 8,167.03 8,089.75
Year Ending Dec-17 8,768.47 8,761.27 8,763.77 8,618.63 8,486.75
Earnings (per share)
Quarter Ending Sep-16 0.27 0.27 0.27 0.27 0.27
Quarter Ending Dec-16 0.29 0.29 0.29 0.28 0.29
Year Ending Dec-16 1.10 1.10 1.10 1.09 1.06
Year Ending Dec-17 1.26 1.26 1.26 1.24 1.20

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-16 0 0 0 0
Quarter Ending Dec-16 0 0 0 0
Year Ending Dec-16 0 0 0 0
Year Ending Dec-17 1 0 1 0
Earnings
Quarter Ending Sep-16 1 0 1 0
Quarter Ending Dec-16 1 0 1 0
Year Ending Dec-16 1 0 2 0
Year Ending Dec-17 1 0 2 0

Analyst Research Reports

Report Title Price
Provider : Stock Traders Daily
$20.00
Provider : New Constructs, LLC
$25.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : MacroRisk Analytics/EconomicInvestor
$25.00
Provider : ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.